Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Exenatide × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Blood Specimen Collection 112 Surveys and Questionnaires 109 Specimen Handling 50 Observation 40 Interviews as Topic 34 Radiotherapy 34 Drug Therapy 26 Magnetic Resonance Spectroscopy 25 Biopsy 23 Surgical Procedures, Operative 23 Data Collection 21 Immune Checkpoint Inhibitors 20 Magnetic Resonance Imaging 18 Nivolumab 18 Therapeutics 17 Watchful Waiting 17 Liquid Biopsy 16 Standard of Care 14 Immunotherapy 12 Radiosurgery 12 enzalutamide 12 palbociclib 12 Bevacizumab 11 Hematologic Tests 11 Positron Emission Tomography Computed Tomography 11 apalutamide 11 pembrolizumab 11 Focus Groups 10 Restraint, Physical 10 Tomography, X-Ray Computed 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05663515 2026-02-12

EXCEED

AstraZeneca

24,000 enrolled

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡